Health Care & Life Sciences » Pharmaceuticals | Myungmoon Pharmaceutical Co. Ltd.

Myungmoon Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
103,723
105,421
125,101
142,180
140,138
147,499
Cost of Goods Sold (COGS) incl. D&A
53,260
51,720
62,778
66,362
61,264
73,550
Gross Income
50,463
53,700
62,323
75,818
78,874
73,948
SG&A Expense
45,004
48,574
61,668
63,691
69,369
66,943
EBIT
4,102
3,726
2,582
10,058
7,473
4,937
Unusual Expense
381
290
370
10
3,939
175
Non Operating Income/Expense
778
362
4,437
1,021
829
228
Interest Expense
3,602
3,908
3,351
3,040
2,361
3,250
Pretax Income
1,097
686
10,453
8,187
10,106
1,893
Income Tax
896
729
7,411
1,713
1,975
1,565
Consolidated Net Income
201
43
17,864
6,474
8,131
328
Net Income
1,026
761
16,135
6,746
7,807
988
Net Income After Extraordinaries
1,026
761
16,135
6,746
7,807
988
Net Income Available to Common
1,026
761
16,135
6,746
7,807
988
EPS (Basic)
53.10
39.62
835.64
310.50
313.44
41
Basic Shares Outstanding
19
19
19
22
25
24
EPS (Diluted)
52.93
39.45
836.07
310.37
313.41
40.51
Diluted Shares Outstanding
19
19
19
22
25
24
EBITDA
6,357
5,940
560
12,060
9,453
6,851
Other Operating Expense
1,358
1,400
3,237
2,069
2,031
2,068
Non-Operating Interest Income
200
216
287
159
226
153
Minority Interest Expense
825
804
1,729
272
324
660

About Myungmoon Pharmaceutical Co.

View Profile
Address
26 Jeyakgongdan 2-gil
Hwaseong GY 18622
Korea, Republic Of
Employees -
Website http://www.mmpharm.co.kr
Updated 07/08/2019
MyungMoon Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include ethical drugs (ETC), over-the-counter drugs (OTC) and indication drugs. The ethical drugs include anesthetic agent, analgesic agent, anti-epileptics, anti-depressants, anti-diabetics, anti-osteoporosis and others.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.